Sai Parenterals has strengthened its Australian OTC business with a fresh AU$30 million three-year supply agreement, taking its total contracted OTC supply commitments in the country to AU$232 million, or about ₹1,506 crore. The latest renewal follows a larger AU$202 million agreement signed in July, with the company looking to shift production from third-party manufacturers to its own facilities.
